HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charbel Mounayer Selected Research

Charbel Mounayer Research Topics

Disease

22Intracranial Aneurysm (Cerebral Aneurysm)
12/2021 - 06/2002
21Aneurysm (Aneurysms)
09/2021 - 06/2002
4Ischemic Stroke
04/2022 - 02/2004
3Arteriovenous Malformations (Arteriovenous Malformation)
06/2019 - 11/2007
3Thrombosis (Thrombus)
05/2017 - 11/2003
2Stroke (Strokes)
05/2022 - 09/2019
2Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2019 - 11/2003
2Hemorrhage
12/2019 - 01/2007
2Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
10/2012 - 05/2008
1Meningioma (Meningiomas)
05/2022
1Wounds and Injuries (Trauma)
02/2020
1Osteoarthritis
12/2017
1Ischemia
05/2017
1Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation)
03/2016
1Blister (Bulla)
12/2013
1Dissection Internal Carotid Artery
10/2012
1Shock
01/2007
1Intracranial Arterial Diseases
10/2005
1Pathologic Constriction (Stenosis)
10/2005
1Paraganglioma (Paragangliomas)
10/2004
1Rupture
05/2004

Drug/Important Bio-Agent (IBA)

2Biological ProductsIBA
05/2021 - 02/2020
2PlatinumIBA
05/2007 - 09/2004
1Biomarkers (Surrogate Marker)IBA
05/2022
1trans-sodium crocetinate (crocetin)IBA
05/2022
1SilkFDA Link
12/2021
1N 30IBA
09/2021
1CollagenIBA
05/2021
1ElastinIBA
05/2021
1SolareIBA
09/2014
1ethylene-vinyl alcohol copolymerIBA
07/2011
1Onyx 18IBA
11/2007
1CyanoacrylatesIBA
10/2004
1N(6)-allyl-N(6)-cyclohexyladenosineIBA
02/2004
1Abciximab (ReoPro)FDA Link
11/2003
1Hemostatics (Antihemorrhagics)IBA
06/2002

Therapy/Procedure

21Stents
05/2021 - 06/2002
6Therapeutics
12/2021 - 08/2006
5Endovascular Procedures
01/2018 - 12/2005
3Thrombectomy
05/2022 - 10/2017
3Punctures
01/2007 - 06/2002
2Retreatment
12/2019 - 11/2003
2Catheters
06/2019 - 11/2003
2Aftercare (After-Treatment)
12/2017 - 01/2007
1Embolic Protection Devices
09/2019
1Radiotherapy
06/2019
1Intra-Articular Injections
12/2017
1Emergency Treatment
12/2013
1Ventriculostomy
05/2008
1Intralesional Injections
10/2004